CD8A and breast cancer: In breast cancer, particularly in TNBC, TILs are positively correlated with a favorable prognosis, while the presence of CD8+ TILs, including a subpopulation of tissue-resident memory T (TRM) cells, is associated with increased response rates to anti-PD-1 antibodies [152].